Texas Health and Safety Code - HEALTH & SAFETY § 491.052. Patient Eligibility

(A) has a life-threatening illness or severely debilitating illness;

(B) has considered all other treatment options currently approved by the United States Food and Drug Administration;  and

(C) has given written informed consent for access to the treatment;  and

(A) attests to the patient's life-threatening illness or severely debilitating illness and the patient's eligibility under this section;  and

(B) recommends the treatment for the patient based on analysis of the patient's genomic sequence, human chromosomes, deoxyribonucleic acid, ribonucleic acid, genes, gene products such as enzymes and other types of proteins, or metabolites.